Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2051332

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2051332

Amniotic Membrane Market, By Product Type By Application, By End User, and By Region

PUBLISHED:
PAGES: 154 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Amniotic Membrane Market is estimated to be valued at USD 5.23 Bn in 2026 and is expected to reach USD 12.46 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5.23 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 13.20% 2033 Value Projection: USD 12.46 Bn

Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids. According to a study published by the National Center for Biotechnology Information (NCBI) in February 2022, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.

Market Dynamics

Market players are focused on research and development activities to obtain approvals for novel products or techniques associated with amniotic membrane, this could contribute to the growth of the market over the forecast period. For instance, in 2018, MiMedx, an American biomedical company received the status of Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Administration for its product AmnioFix, an amniotic membrane that is designed for use in osteoarthritis treatment.

Market players are focusing on product launches, which is expected to strengthen their position in the global market. For instance, on February, 2021, Integra LifeSciences, an American medical technology company launched AmnioExcel Plus amniotic membrane that helps in wound care.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the amniotic membrane market globally. For instance, in 2017, Organogenesis Holdings Inc., an American regenerative medicine company acquired NuTech Medical, an American biologics company, to expand their company product portfolio and support the development of next generation amniotic membrane products.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the global amniotic membrane market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
  • The global amniotic membrane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the amniotic membrane market.

Market Segmentation

  • By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
  • Amniotic Suspensions
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Wound Care
  • Orthopedics
  • Ophthalmology
  • Others
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospital
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research and Academic Institutes
  • By Geography (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Smith & Nephew
  • Applied Biologics
  • Organogenesis Holdings Inc.
  • Osiris Therapeutics, Inc.
  • Alliqua BioMedical, Inc.
  • Amnio Technology, LLC
  • Next Biosciences
  • Integra LifeSciences
  • MiMedx
  • LifeCell International
  • Human Regenerative Technologies, LLC
  • Amniox Medical, Inc.
  • Skye Biologics Inc.
  • Wright Medical
  • TissueTech
  • Katena Products, Inc.
  • NuVision Biotherapies
  • Surgenex
  • Ventris Medical
Product Code: CMI4477

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Amniotic Membrane Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Amniotic Suspensions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends

5. Global Amniotic Membrane Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Wound Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends

6. Global Amniotic Membrane Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Amniotic Membrane Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Smith & Nephew
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Applied Biologics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Organogenesis Holdings Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Osiris Therapeutics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Alliqua BioMedical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Amnio Technology, LLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Next Biosciences
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Integra LifeSciences
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • MiMedx
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • LifeCell International
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Human Regenerative Technologies, LLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Amniox Medical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Skye Biologics Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Wright Medical
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • TissueTech
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Katena Products, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • NuVision Biotherapies
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Surgenex
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Ventris Medical
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!